Research

Thomas P. Stossel, MD, MD (Hon), is a visiting scholar at the American Enterprise Institute and professor emeritus at Harvard…

As reported, earlier this year, a top medical journal ignited a backlash by referring to "research parasites", also…

Recently, we covered Thomas Stossel, M.D.’s new book, Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical…

Long a champion of physician and industry collaboration, Thomas Stossel, M.D., has published a new book entitled …

Developing a new prescription medicine that gains marketing approval is estimated to cost drugmakers $2.6 billion according to a…

Eli Lilly, Bayer Healthcare, and Boehringer Ingelheim have announced their plans to increase access to their clinical trial…

Before the break the United States Senate Special Committee on Aging held a roundtable event: Tackling Diseases of Aging: Why…

The Nation once led the world in investments in research and development (R&D) as a share of gross domestic product (GDP), but…

Over the past few weeks, the National Institutes of Health (NIH) has announced a number of initiatives and programs.  For example,…

Acccording to some reports deaths from painkiller overdoses have tripled over the last decade and led to the deaths of 14,800…